The Biggest Biotech IPO Of 2019 Provides More Than Profits To Microsoft
When Microsoft invested in Adaptive Biotechnologies – a an experimental health-care firm, in late 2017, it aimed to test out how its advanced cloud technology works in the area of life sciences as well as to make some profits as a major shareholders of the company. And now it appears that both the aims of…









